Check out the Detailed Program! Learn More

Cyclic vomiting syndrome and its esophageal manifestations

Cyclic vomiting syndrome (CVS) is a disorder marked by recurrent, stereotyped episodes of intense nausea and vomiting separated by periods of relative wellness. Episodes can last for hours or days, and many patients recognize a similar pattern each time. Although the condition is often discussed as a gastric or brain–gut disorder, the esophagus may experience substantial consequences.

Repeated retching exposes the esophageal lining to gastric acid, digestive enzymes, and mechanical pressure. Symptoms may include burning chest discomfort, painful swallowing, difficulty swallowing, regurgitation, or a persistent sensation of irritation after an episode has ended.

Understanding these manifestations helps clinicians separate injury caused by vomiting from conditions that may trigger vomiting, including achalasia, gastroesophageal reflux disease, medication effects, and obstruction. Prompt assessment also reduces the risk of dehydration, bleeding, electrolyte disturbances, and avoidable esophageal damage.

Recognizing the vomiting pattern

CVS commonly follows a recognizable sequence: a prodromal phase with nausea, sweating, pallor, abdominal discomfort, or anxiety; an acute phase with repetitive vomiting and retching; and a recovery phase in which oral intake gradually returns. Some patients have symptom-free intervals lasting weeks or months.

Common triggers include infections, emotional stress, sleep deprivation, fasting, certain foods, menstruation, and exposure to cannabis in susceptible individuals. A detailed history should document episode frequency, duration, symptom-free periods, emergency visits, medication use, and any relationship to meals or physical activity.

How vomiting affects the esophagus

Forceful retching can cause inflammation known as reflux esophagitis, particularly when repeated exposure to stomach contents weakens mucosal defenses. Patients may report heartburn, chest pain, sour regurgitation, or odynophagia. Small mucosal tears near the junction of the esophagus and stomach can produce blood in vomit, while severe pressure injury may rarely lead to a full-thickness rupture.

Persistent symptoms between episodes deserve attention. Reflux-related inflammation can cause narrowing, and repeated injury may contribute to hypersensitivity or altered swallowing behavior. Hoarseness, chronic cough, and throat irritation can also occur when reflux reaches the upper airway.

Separating CVS from other disorders

CVS is a clinical diagnosis supported by a consistent episode pattern and the exclusion of important alternatives. Endoscopy, imaging, laboratory testing, and selected motility studies may be appropriate when symptoms are atypical, progressive, or accompanied by weight loss, anemia, fever, gastrointestinal bleeding, or persistent dysphagia.

The following distinctions can guide evaluation:

Condition Features that may point toward it Potential esophageal relevance
Cyclic vomiting syndrome Recurrent, similar episodes with well intervals Retching injury, reflux, mucosal tears
Achalasia Progressive dysphagia, regurgitation of retained food, weight loss Esophageal dilation and impaired clearance
GERD Chronic heartburn, acid regurgitation, meal-related symptoms Esophagitis, stricture, Barrett’s changes
Gastroparesis Early fullness, bloating, vomiting of undigested food Increased reflux burden and poor clearance
Cannabinoid hyperemesis Recurrent vomiting associated with cannabis exposure Repeated acid and mechanical injury

Testing esophageal function

Upper endoscopy can identify erosions, ulcers, strictures, bleeding, retained food, or other structural problems. It may be performed after stabilization rather than during severe dehydration unless alarm symptoms require urgent investigation. Biopsies can help assess conditions such as eosinophilic esophagitis when swallowing problems persist.

High-resolution manometry measures pressure and coordination throughout the esophagus. It is useful when dysphagia, regurgitation, or suspected achalasia remains unexplained by endoscopy. It also has a role in selected surgical evaluations; clinicians can review esophageal manometry guidance when considering how motility findings may affect treatment planning before bariatric surgery.

Testing should answer a clinical question rather than become an automatic part of every CVS evaluation. Results need to be interpreted alongside the symptom timeline, medication history, nutritional status, and findings from endoscopy or imaging.

Protecting the esophagus during treatment

Management begins with a coordinated plan for acute episodes and prevention. During an attack, clinicians may use antiemetic medication, intravenous fluids, electrolyte replacement, and a quiet, low-stimulation environment. Acid suppression may help patients with reflux symptoms or documented mucosal inflammation, while analgesics should be selected carefully because some drugs can worsen nausea or gastrointestinal injury.

Between episodes, preventive treatment may involve a gastroenterology review, trigger avoidance, sleep regulation, behavioral support, and medication tailored to the patient’s history. Cannabis cessation is essential when cannabinoid hyperemesis is possible. Small, gradual meals and careful hydration can support recovery, although dietary changes do not replace medical assessment.

Practical priorities for clinical care

A written plan can reduce delays when symptoms recur and help distinguish a familiar episode from a dangerous complication. Patients and care teams should agree on when home medication is appropriate and when urgent evaluation is needed.

  • Record the timing, duration, triggers, and severity of each vomiting episode.
  • Seek urgent care for blood in vomit, severe chest pain, fainting, breathing difficulty, or sudden worsening after retching.
  • Replace fluids and electrolytes under medical guidance, especially when vomiting continues.
  • Arrange specialist review for persistent dysphagia, unexplained weight loss, anemia, or symptoms between episodes.
  • Discuss preventive therapy and possible cannabis-related vomiting openly and without judgment.

Clear communication among primary care clinicians, gastroenterologists, emergency teams, dietitians, and behavioral health professionals can improve continuity. Esophageal symptoms should be treated as clinically meaningful rather than dismissed as an unavoidable part of vomiting.

Early recognition of cyclic vomiting syndrome and its esophageal manifestations allows treatment to address both the recurring episodes and the injury they may cause. Seek professional evaluation for repeated vomiting, swallowing difficulty, chest pain, or evidence of bleeding, and use specialist follow-up to build a safer long-term management plan.

About ISDE

The ISDE is an international, multispecialty society devoted to the study of the esophagus in disease and in health that was founded in 1979. The aims of the ISDE are to promote the exchange of scientific and medical knowledge among specialists in the field, to maintain interchange with organizations and industries, and to encourage basic and clinical research in fields related to the esophagus. In order to promote the professional and educational development of individuals interested in the esophagus, the ISDE sponsors its own journal, international congresses, and other educational programs. The ISDE Secretariat was in Tokyo, Japan, from 1979 to 2004, and then resided in Los Angeles, California, from 2004 through 2010. Since 2010 the Secretariat has been in Vancouver, British Columbia, under the auspices of International Conferences Service, Ltd. The ISDE welcomes participation by existing members and encourages individuals who are professionally interested in the esophagus to become members. Benefits include reduced registration fees at our congresses and other educational offerings, restricted access to website content and member search capability, access to webcasts, reduced subscription rates for our journal, and the opportunity to help lead this organization into a position of leadership in the worldwide medical community.